Literature DB >> 31327527

An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma.

Cyril Neftel1, Julie Laffy2, Mariella G Filbin3, Toshiro Hara4, Marni E Shore5, Gilbert J Rahme5, Alyssa R Richman5, Dana Silverbush5, McKenzie L Shaw3, Christine M Hebert5, John Dewitt5, Simon Gritsch5, Elizabeth M Perez5, L Nicolas Gonzalez Castro6, Xiaoyang Lan5, Nicholas Druck7, Christopher Rodman7, Danielle Dionne8, Alexander Kaplan9, Mia S Bertalan9, Julia Small10, Kristine Pelton11, Sarah Becker11, Dennis Bonal12, Quang-De Nguyen12, Rachel L Servis7, Jeremy M Fung7, Ravindra Mylvaganam7, Lisa Mayr12, Johannes Gojo13, Christine Haberler14, Rene Geyeregger15, Thomas Czech16, Irene Slavc13, Brian V Nahed10, William T Curry10, Bob S Carter10, Hiroaki Wakimoto10, Priscilla K Brastianos9, Tracy T Batchelor9, Anat Stemmer-Rachamimov7, Maria Martinez-Lage7, Matthew P Frosch7, Ivan Stamenkovic17, Nicolo Riggi17, Esther Rheinbay18, Michelle Monje19, Orit Rozenblatt-Rosen8, Daniel P Cahill10, Anoop P Patel20, Tony Hunter21, Inder M Verma21, Keith L Ligon22, David N Louis7, Aviv Regev23, Bradley E Bernstein5, Itay Tirosh24, Mario L Suvà25.   

Abstract

Diverse genetic, epigenetic, and developmental programs drive glioblastoma, an incurable and poorly understood tumor, but their precise characterization remains challenging. Here, we use an integrative approach spanning single-cell RNA-sequencing of 28 tumors, bulk genetic and expression analysis of 401 specimens from the The Cancer Genome Atlas (TCGA), functional approaches, and single-cell lineage tracing to derive a unified model of cellular states and genetic diversity in glioblastoma. We find that malignant cells in glioblastoma exist in four main cellular states that recapitulate distinct neural cell types, are influenced by the tumor microenvironment, and exhibit plasticity. The relative frequency of cells in each state varies between glioblastoma samples and is influenced by copy number amplifications of the CDK4, EGFR, and PDGFRA loci and by mutations in the NF1 locus, which each favor a defined state. Our work provides a blueprint for glioblastoma, integrating the malignant cell programs, their plasticity, and their modulation by genetic drivers.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CDK4; EGFR; NF1; PDGFRA; glioblastoma IDH-wildtype; glioblastoma stem cells; glioblastoma subtypes; lineage tracing; single-cell RNA-sequencing

Mesh:

Year:  2019        PMID: 31327527      PMCID: PMC6703186          DOI: 10.1016/j.cell.2019.06.024

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  32 in total

1.  Asymmetric distribution of EGFR receptor during mitosis generates diverse CNS progenitor cells.

Authors:  Yu Sun; Susan K Goderie; Sally Temple
Journal:  Neuron       Date:  2005-03-24       Impact factor: 17.173

2.  Loss of Cdk2 and Cdk4 induces a switch from proliferation to differentiation in neural stem cells.

Authors:  Shuhui Lim; Philipp Kaldis
Journal:  Stem Cells       Date:  2012-07       Impact factor: 6.277

3.  Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.

Authors:  Hiroaki Wakimoto; Gayatry Mohapatra; Ryuichi Kanai; William T Curry; Stephen Yip; Mai Nitta; Anoop P Patel; Zachary R Barnard; Anat O Stemmer-Rachamimov; David N Louis; Robert L Martuza; Samuel D Rabkin
Journal:  Neuro Oncol       Date:  2011-11-07       Impact factor: 12.300

4.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.

Authors:  Shideng Bao; Qiulian Wu; Roger E McLendon; Yueling Hao; Qing Shi; Anita B Hjelmeland; Mark W Dewhirst; Darell D Bigner; Jeremy N Rich
Journal:  Nature       Date:  2006-10-18       Impact factor: 49.962

5.  Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics.

Authors:  Andrea Sottoriva; Inmaculada Spiteri; Sara G M Piccirillo; Anestis Touloumis; V Peter Collins; John C Marioni; Christina Curtis; Colin Watts; Simon Tavaré
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-14       Impact factor: 11.205

6.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

7.  Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.

Authors:  Roel G W Verhaak; Katherine A Hoadley; Elizabeth Purdom; Victoria Wang; Yuan Qi; Matthew D Wilkerson; C Ryan Miller; Li Ding; Todd Golub; Jill P Mesirov; Gabriele Alexe; Michael Lawrence; Michael O'Kelly; Pablo Tamayo; Barbara A Weir; Stacey Gabriel; Wendy Winckler; Supriya Gupta; Lakshmi Jakkula; Heidi S Feiler; J Graeme Hodgson; C David James; Jann N Sarkaria; Cameron Brennan; Ari Kahn; Paul T Spellman; Richard K Wilson; Terence P Speed; Joe W Gray; Matthew Meyerson; Gad Getz; Charles M Perou; D Neil Hayes
Journal:  Cancer Cell       Date:  2010-01-19       Impact factor: 31.743

8.  Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice.

Authors:  Dinorah Friedmann-Morvinski; Eric A Bushong; Eugene Ke; Yasushi Soda; Tomotoshi Marumoto; Oded Singer; Mark H Ellisman; Inder M Verma
Journal:  Science       Date:  2012-10-18       Impact factor: 47.728

9.  RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome.

Authors:  Bo Li; Colin N Dewey
Journal:  BMC Bioinformatics       Date:  2011-08-04       Impact factor: 3.307

10.  A restricted cell population propagates glioblastoma growth after chemotherapy.

Authors:  Jian Chen; Yanjiao Li; Tzong-Shiue Yu; Renée M McKay; Dennis K Burns; Steven G Kernie; Luis F Parada
Journal:  Nature       Date:  2012-08-23       Impact factor: 49.962

View more
  413 in total

1.  Glioblastoma cell populations with distinct oncogenic programs release podoplanin as procoagulant extracellular vesicles.

Authors:  Nadim Tawil; Rayhaan Bassawon; Brian Meehan; Ali Nehme; Laura Montermini; Tenzin Gayden; Nicolas De Jay; Cristiana Spinelli; Shilpa Chennakrishnaiah; Dongsic Choi; Lata Adnani; Michele Zeinieh; Nada Jabado; Claudia L Kleinman; Michael Witcher; Yasser Riazalhosseini; Nigel S Key; David Schiff; Steven P Grover; Nigel Mackman; Charles P Couturier; Kevin Petrecca; Mario L Suvà; Anoop Patel; Itay Tirosh; Hamed Najafabadi; Janusz Rak
Journal:  Blood Adv       Date:  2021-03-23

Review 2.  Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.

Authors:  Patrick Y Wen; Michael Weller; Eudocia Quant Lee; Brian M Alexander; Jill S Barnholtz-Sloan; Floris P Barthel; Tracy T Batchelor; Ranjit S Bindra; Susan M Chang; E Antonio Chiocca; Timothy F Cloughesy; John F DeGroot; Evanthia Galanis; Mark R Gilbert; Monika E Hegi; Craig Horbinski; Raymond Y Huang; Andrew B Lassman; Emilie Le Rhun; Michael Lim; Minesh P Mehta; Ingo K Mellinghoff; Giuseppe Minniti; David Nathanson; Michael Platten; Matthias Preusser; Patrick Roth; Marc Sanson; David Schiff; Susan C Short; Martin J B Taphoorn; Joerg-Christian Tonn; Jonathan Tsang; Roel G W Verhaak; Andreas von Deimling; Wolfgang Wick; Gelareh Zadeh; David A Reardon; Kenneth D Aldape; Martin J van den Bent
Journal:  Neuro Oncol       Date:  2020-08-17       Impact factor: 12.300

3.  Circular RNA-encoded oncogenic E-cadherin variant promotes glioblastoma tumorigenicity through activation of EGFR-STAT3 signalling.

Authors:  Xinya Gao; Xin Xia; Fanying Li; Maolei Zhang; Huangkai Zhou; Xujia Wu; Jian Zhong; Zheng Zhao; Kun Zhao; Dawei Liu; Feizhe Xiao; Qiang Xu; Tao Jiang; Bo Li; Shi-Yuan Cheng; Nu Zhang
Journal:  Nat Cell Biol       Date:  2021-03-04       Impact factor: 28.824

4.  Cell Lineage-Based Stratification for Glioblastoma.

Authors:  Zilai Wang; Daochun Sun; Yu-Jung Chen; Xuanhua Xie; Yufeng Shi; Viviane Tabar; Cameron W Brennan; Tejus A Bale; Chenura D Jayewickreme; Dan R Laks; Sheila Alcantara Llaguno; Luis F Parada
Journal:  Cancer Cell       Date:  2020-07-09       Impact factor: 31.743

5.  Spatial enrichment of cellular states in glioblastoma.

Authors:  Charles G Eberhart; Eli E Bar
Journal:  Acta Neuropathol       Date:  2020-05-24       Impact factor: 17.088

Review 6.  Metabolic heterogeneity and adaptability in brain tumors.

Authors:  Christian E Badr; Daniel J Silver; Florian A Siebzehnrubl; Loic P Deleyrolle
Journal:  Cell Mol Life Sci       Date:  2020-06-06       Impact factor: 9.261

7.  Driving mesenchymal transition in glioblastoma.

Authors:  Michael Platten
Journal:  Neuro Oncol       Date:  2020-01-11       Impact factor: 12.300

Review 8.  Advancing Cancer Research and Medicine with Single-Cell Genomics.

Authors:  Bora Lim; Yiyun Lin; Nicholas Navin
Journal:  Cancer Cell       Date:  2020-04-13       Impact factor: 31.743

Review 9.  The multifaceted NF-kB: are there still prospects of its inhibition for clinical intervention in pediatric central nervous system tumors?

Authors:  Mariana Medeiros; Marina Ferreira Candido; Elvis Terci Valera; María Sol Brassesco
Journal:  Cell Mol Life Sci       Date:  2021-07-31       Impact factor: 9.261

10.  P32-specific CAR T cells with dual antitumor and antiangiogenic therapeutic potential in gliomas.

Authors:  Liat Rousso-Noori; Ignacio Mastandrea; Shauli Talmor; Tova Waks; Anat Globerson Levin; Maarja Haugas; Tambet Teesalu; Luis Alvarez-Vallina; Zelig Eshhar; Dinorah Friedmann-Morvinski
Journal:  Nat Commun       Date:  2021-06-14       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.